18 Jan 2023 Annals of the Rheumatic Diseases publishes results from two bimekizumab Phase 3 studies in axial spondyloarthritis Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us